Amundi Asia Pacific Market Monthly Commentary - March 2021
Tuesday 02 March 2021
The pandemic outbreak is being a real turning point for the mRNA field as the success of the mRNA-based COVID-19 vaccine is certainly contributing to unlock the power of this technology.
The rapid progress of mRNA vaccines proves that the RNA therapeutics market was ready to take off well before the pandemic. A combination of factors has now prepared the mRNA space to shape the face of medicine.
The mRNA field now better equipped for the race to the market.
In this scenario, which themes and stocks are the winners?
Click below to read the full document.
For more than 7 years now, Amundi makes accessible online its research and analysis papers on its Research Center.